by The mineral supplements market size is poised to grow by USD 29.66 billion by 2033 from USD 16.53 billion in 2023, exhibiting a CAGR of 6.02% during the forecast period 2024-2033.
Key Points
- Asia-Pacific dominated the market with the largest market share of 40% in 2023.
- By product, the calcium segment has contributed the largest market share of 42% in 2023.
- By formulation, the tablet segment led the market with the biggest market share of 36% in 2023.
- By application, the general health segment has led the major market share of 41% in 2023.
- By end-use, the adult segment has accounted more than 48% of market share in 2023.
- By sales channel, the pharmacies & drug stores segment dominated the market in 2023.
Precedence Research has conducted a comprehensive market study that provides valuable insights into the performance of the market during the forecast period. The study identifies significant trends that are shaping the growth of the Mineral supplements market. In this recently published report, essential dynamics such as drivers, restraints, and opportunities are highlighted for both established market players and emerging participants involved in production and supply.
To begin with, the Mineral supplements Market report features an executive summary that offers a concise overview of the marketplace. It outlines the key players and industry categories expected to have an impact on the market in the coming years. The executive summary provides an unbiased summary of the market.
Get a Sample Report: https://www.precedenceresearch.com/sample/3885
Mineral Supplements Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 6.02% |
| Global Market Size in 2023 | USD 16.53 Billion |
| Global Market Size by 2033 | USD 29.66 Billion |
| Largest Market | Asia Pacific |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Product, By Formulation, By Application, By End-Use, and By Sales Channel |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: Hearing Loss Disease Treatment Market Size, Share, Report 2033
The empirical study on the global Mineral supplements market primarily focuses on the drivers in subsequent sections. It demonstrates how changing demographics are projected to influence the supply and demand dynamics in the Mineral supplements Market. Our market report for the Mineral supplements market also delves into the significant rules and regulations that are likely to impact the future growth of this sector. Moreover, in order to comprehend the underlying demand factors, industry experts have provided insights into its fundamental origins.
Mineral Supplements Market Companies
- Glanbia, plc.
- Abbott
- Nestle
- Biovea
- Herbalife International of America, Inc.
- Sanofi
- Amway
- Bayer AG
- Omega Protein Corporation
- Bio Botanica, Inc.
- Pharmavite LLC
- DSM
- Nu Skin
Data Sources and Methodology
To gather comprehensive insights on the Global Mineral supplements Market, we relied on a range of data sources and followed a well-defined methodology. Our approach involved interactions with industry experts and key stakeholders across the market’s value chain, including management organizations, processing organizations, and analytics service providers.
We followed a rigorous data analysis process to ensure the quality and credibility of our research. The gathered information was carefully evaluated, and relevant quantitative data was subjected to statistical analysis. By employing robust analytical techniques, we were able to derive meaningful insights and present a comprehensive overview of the Global Mineral supplements Market.
The most resonating, simple, genuine, and important causes because of which you must decide to buy the Mineral supplements market report exclusively from precedence research
- The research report has been meticulously crafted to provide comprehensive knowledge on essential marketing strategies and a holistic understanding of crucial marketing plans spanning the forecasted period from 2024 to 2033.
Key Features of the Report:
- Comprehensive Coverage: The report extensively encompasses a detailed explanation of highly effective analytical marketing methods applicable to companies across all industry sectors.
- Decision-Making Enhancement: It outlines a concise overview of the decision-making process while highlighting key techniques to enhance it, ensuring favorable business outcomes in the future.
- Articulated R&D Approach: The report presents a well-defined approach to conducting research and development (R&D) activities, enabling accurate data acquisition on current and future marketing conditions.
Market Segmentation:
By Product
- Calcium
- Magnesium
- Iron
- Potassium
- Zinc
- Chromium
- Selenium
- Others
By Formulation
- Capsule
- Tablet
- Powder
- Liquid/Gel
- Others
By Application
- General Health
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Others
By End-Use
- Adults
- Geriatric
- Pregnant Women
- Children
- Infants
By Sales Channel
- Pharmacies & Drug Stores
- Supermarkets & Hypermarkets
- Online Channels
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Reasons to Consider Purchasing the Report:
- Enhance your market research capabilities by accessing this comprehensive and precise report on the global Mineral supplements market.
- Gain a thorough understanding of the overall market landscape and be prepared to overcome challenges while ensuring robust growth.
- Benefit from in-depth research and analysis of the latest trends shaping the global Mineral supplements market.
- Obtain detailed insights into evolving market trends, current and future technologies, and strategic approaches employed by key players in the global Mineral supplements market.
- Receive valuable recommendations and guidance for both new entrants and established players seeking further market expansion.
- Discover not only the cutting-edge technological advancements in the global Mineral supplements market but also the strategic plans of industry leaders.
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Mineral Supplements Market
5.1. COVID-19 Landscape: Mineral Supplements Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Mineral Supplements Market, By Product
8.1. Mineral Supplements Market Revenue and Volume, by Product, 2024-2033
8.1.1. Calcium
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Magnesium
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Iron
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Potassium
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Zinc
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
8.1.6. Chromium
8.1.6.1. Market Revenue and Volume Forecast (2021-2033)
8.1.7. Selenium
8.1.7.1. Market Revenue and Volume Forecast (2021-2033)
8.1.8. Others
8.1.8.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Mineral Supplements Market, By Formulation
9.1. Mineral Supplements Market Revenue and Volume, by Formulation, 2024-2033
9.1.1. Capsule
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Dessert
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Powder
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Liquid/Gel
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
9.1.5. Others
9.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Mineral Supplements Market, By Application
10.1. Mineral Supplements Market Revenue and Volume, by Application, 2024-2033
10.1.1. General Health
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Bone & Joint Health
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Gastrointestinal Health
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Immunity
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Mineral Supplements Market, By End-Use
11.1. Mineral Supplements Market Revenue and Volume, by End-Use, 2024-2033
11.1.1. Adults
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Geriatric
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
11.1.3. Pregnant Women
11.1.3.1. Market Revenue and Volume Forecast (2021-2033)
11.1.4. Children
11.1.4.1. Market Revenue and Volume Forecast (2021-2033)
11.1.5. Infants
11.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. Global Mineral Supplements Market, By Sales Channel
12.1. Mineral Supplements Market Revenue and Volume, by Sales Channel, 2024-2033
12.1.1. Pharmacies & Drug Stores
12.1.1.1. Market Revenue and Volume Forecast (2021-2033)
12.1.2. Supermarkets & Hypermarkets
12.1.2.1. Market Revenue and Volume Forecast (2021-2033)
12.1.3. Online Channels
12.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 13. Global Mineral Supplements Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.1.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.1.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.1.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.1.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.1.6.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.1.6.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.7.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.1.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.1.7.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.1.7.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.2.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.2.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.7. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.2.8. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.9.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.2.9.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.10. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.2.11. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.12.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.2.12.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.12.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.2.13. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.14.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.2.14.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.14.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.2.15. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.3.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.3.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.6.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.3.7. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.8.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.3.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.8.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.3.9. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.10.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.3.10.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.10.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.3.10.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.11.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.3.11.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.11.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.3.11.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.4.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.6.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.4.7. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.8.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.4.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.8.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.4.9. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.10.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.4.10.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.10.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.4.10.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.11.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.4.11.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.11.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.4.11.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.5.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.5.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.5.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.5.6.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.5.7. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.8.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.5.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.5.8.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.5.8.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
Chapter 14. Company Profiles
14.1. Glanbia, plc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Abbott
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Nestle
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Biovea
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Herbalife International of America, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Sanofi
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Amway
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Bayer AG
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Omega Protein Corporation
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Bio Botanica, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Unlocking Market Insights through Data Excellence
The “Precedence Statistics” flexible dashboard is a powerful tool that offers real-time news updates, economic and market forecasts, and customizable reports. It can be configured to support a wide range of analysis styles and strategic planning needs. This tool empowers users to stay informed and make data-driven decisions in various scenarios, making it a valuable asset for businesses and professionals looking to stay ahead in today’s dynamic and data-driven world.
Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com
Precedence Statistics – Empowering Your Data Insights
Contact Us
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
